Skip to main content

Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Product Alert – Mirogabalin Besylate

Product Alert – Mirogabalin Besylate

Dr. Reddy's Offerings*:

  • Planning USDMF by January 2025
  • Offers crystalline Form-1
  • Non-GMP API and COA are available.

Quality Assurance through cGMP API Manufacturing

  • Manufacturing facilities have successfully undergone inspections by international regulatory authorities.
  • Partnerships with reliable key starting materials (KSM) suppliers for timely deliveries and strict adherence to specifications.

To learn more, download the product alert on Mirogabalin API HERE.

Should you have any specific queries? I would be happy to schedule a meeting at your earliest convenience.

*Note: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper


No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.